ask="18.77"
ask_size="500"
average_daily_volume="145644"
bid="16.05"
bid_size="400"
book_value="6.55"
change="+0.05"
change_from_200_day_moving_average="2.65"
change_from_50_day_moving_average="1.99"
change_from_52_week_high="-9.45"
change_From_52_week_low="6.03"
change_in_percent="+0.28%"
close="18.05"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-2.68"
ebitda="-63.46M"
eps_estimate_current_year="-2.91"
eps_estimate_next_quarter="-0.73"
eps_estimate_next_year="-3.05"
ex_dividend_date="N/A"
float_shares="11787000"
high="18.24"
high_52_weeks="27.50"
last_trade_date="1/5/2017"
last_trade_price="18.05"
last_trade_size="10408"
last_trade_time="4:00pm"
low="17.71"
low_52_weeks="12.02"
market_capitalization="396.78M"
moving_average_200_day="15.40"
moving_average_50_day="16.06"
name="Adamas Pharmaceuticals
Inc."
notes="N/A"
one_year_target_price="33.57"
open="17.84"
pe_ratio="N/A"
peg_ratio="-0.08"
percent_change_from_200_day_moving_average="+17.20%"
percent_change_from_50_day_moving_average="+12.41%"
percent_change_from_52_week_high="-34.36%"
percent_change_from_52_week_low="+50.17%"
previous_close="18.00"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="2.75"
price_per_sales="373.63"
revenue="1.06M"
shares_outstanding="21982000"
short_ratio="29.71"
stock_exchange="NGM"
symbol="ADMS"
volume="128526"
weeks_range_52="12.02 - 27.50"
